Abbvie Inc (NYSE:ABBV)
Abbvie Inc
NYSE:ABBV
P/E
Price to Earnings
The Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.
P/E
= Market Cap
/ Net Income
Current P/E
ABBV
21.6
Median P/E
ABBV
22.7
Industry P/E
Biotechnology
4.7
P/E History
Statistics
Price to Earnings
Price to Earnings
| 1 Year | 3 Years | 5 Years | |
|---|---|---|---|
| Average | 25.4 | 24.5 | 22.1 |
| Median | 24.8 | 22.7 | 20.6 |
| Min | 20.4 | 11.6 | 11.6 |
| Max | 36.8 | 39.3 | 39.3 |
History Chart
Price to Earnings
Price to Earnings
P/E Forward Multiples
Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
P/E
10.7
2-Years Forward
P/E
12.5
3-Years Forward
P/E
12.6
P/E Across Competitors
ABBV Competitors
Abbvie Inc Competitors
Abbvie Inc Competitors
Relative Valuation Report
View full relative valuation report for Abbvie Inc, which takes into account all ABBV`s valuation multiples.
